ÈËÆÞÖгöÊÓƵ

Skip to main content
Meagan Seay
( out of 165 reviews )

Meagan Seay, DO

Languages spoken: English

Clinical Locations

John A. Moran Eye Center

Salt Lake City
801-581-2352
  • Meagan Seay, DO, specializes in neuro-ophthalmology and treats patients with diseases affecting the optic nerve and eye movements as well as neurologic diseases that affect vision.

    Learn more about Dr. Seay and the conditions she treats by viewing her .

    Board Certification

    American Board of Psychiatry & Neurology (Neurology)

    Patient Rating

    4.8 /5
    ( out of 165 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 24, 2024
    MORAN EYE CENTER

    Very good customer service and care

    September 19, 2024
    MORAN EYE CENTER

    She was very friendly and knowledgeable. Took the time to listen and explain to us our concerns. Would recommend anyone who see her.

    September 16, 2024
    MORAN EYE CENTER

    I highly recommend Dr. Seay's extremely professional and meticulous patient care

    September 06, 2024
    MORAN EYE CENTER

    Professional evaluation and care were outstanding.

    September 06, 2024
    MORAN EYE CENTER

    A great professional

    September 04, 2024
    MORAN EYE CENTER

    Easy to talk to, listens attentively , explains in terms that are easily understood. Makes you feel comfortable throughout your experience.

    July 21, 2024
    MORAN EYE CENTER

    Very friendly and patient. Really giving me the attention to all the details to be sure I get the best care.

    July 19, 2024
    MORAN EYE CENTER

    Very professional and took the time to answer my questions and explain things to me so I understood what was going on.

    July 15, 2024
    MORAN EYE CENTER

    Dr. Seay is a warm, kind & caring individual. She has the expertise to know the condition I suffer from and give me the most current knowledge about it. She also told me if I have further questions to send her a message in My Chart and she would get back with me, so that's reassuring to be able to be heard & be able to question things that a profession might have answers for. She & her staff are top notch!

  • Meagan Seay, DO, specializes in neuro-ophthalmology and treats patients with diseases affecting the optic nerve and eye movements as well as neurologic diseases that affect vision.

    Learn more about Dr. Seay and the conditions she treats by viewing her .

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Primary
    Neurology -Adjunct
    Board Certification
    American Board of Psychiatry & Neurology (Neurology)

    Education history

    Fellowship Neuro-Ophthalmology - New York ÈËÆÞÖгöÊÓƵ Langone Medical Center Fellow
    Neurology - Cleveland Clinic Resident
    Post Graduate Training Ocular Pathology - ÈËÆÞÖгöÊÓƵ of Iowa Hospitals and Clinics Postgraduate Studies
    Osteopathic Medicine - Texas College of Osteopathic Medicine at ÈËÆÞÖгöÊÓƵ of North Texas ÈËÆÞÖгöÊÓƵ Science Center D.O.
    Undergraduate Biochemistry - Abilene Christian ÈËÆÞÖгöÊÓƵ B.S.

    Selected Publications

    Journal Article

    1. Seay MD, Digre KB (2024). The 50th Annual Meeting of the North American Neuro-Ophthalmology Society in Honolulu, Hawaii. J Neuroophthalmol. ()
    2. Hoshina Y, Seay M, Vegunta S, Stulberg EL, Wright MA, Wong KH, Smith TL, Shimura D, Clardy SL (2024). Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. J Neuroophthalmol. ()
    3. Krikova I, Digre KB, Katz BJ, Seay MD, Warner JEA (2024). Migraine, idiopathic intracranial hypertension, and calcitonin gene-related peptide antibodies. Headache. ()
    4. Etheridge T, Jones J, Caskey E, Zielinski BA, Seay MD, Warner JEA (2022). Ophthalmic Artery Obstruction With Focal Cerebral Arteriopathy of Childhood. J Neuroophthalmol, 44(1), e14-e16. ()
    5. Randall DJ, Modersitzki NK, Vegunta S, Seay MD (2022). Optic Disc Edema Associated With Ustekinumab Therapy. J Neuroophthalmol, 44(1), e32-e33. ()
    6. Seay MD, Calix RA, Digre KB (2024). A Great Conversation With Lenworth Johnson. J Neuroophthalmol. ()
    7. Modersitzki NK, Randall DJ, Vegunta S, Seay MD (2022). Novel Report of Ophthalmoparesis Associated With CMT Type 2P Secondary to LRSAM1 Mutation. J Neuroophthalmol, 43(4), e296-e297. ()
    8. Calix RA, Seay MD, Digre KB (2023). A Great Conversation With Deborah Friedman. J Neuroophthalmol, 43(4), 580-588. ()
    9. Seay MD, Calix RA, Digre KB (2023). A Great Conversation With Anthony Arnold. J Neuroophthalmol. ()
    10. Seay MD, Calix RA, Digre KB (2023). A Great Conversation With Michael Slavin. J Neuroophthalmol. ()
    11. Moshirfar M, Williams DJ, Ziari M, Seay MD, Ronquillo YC (2023). Laser-Assisted In Situ Keratomileusis Surgery on a Patient with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease or Neuromyelitis Optica Spectrum Disorder. Case Rep Ophthalmol Med, 2023, 9977513. ()
    12. Ryu BU, Rao AV, Hasegawa N, Katz BJ, Caskey E, Seay MD, Harrie RP, Adesina OO (2023). Three Cases of Bilateral, Asymptomatic Orbital Varices. J Neuroophthalmol. ()
    13. Seay MD, Digre KB (2023). 75th Annual Meeting of the American Academy of Neurology. J Neuroophthalmol. ()
    14. Jebaraj AP, Wilkinson SW, Nydegger JR, Seay MD (2023). Headache, Confusion, and Hearing Loss. J Neuroophthalmol, 43(1), e40. ()
    15. Seay MD, Calix RA, Digre KB (2022). A Great Conversation With Neil Miller. J Neuroophthalmol, 43(1), 141-147. ()
    16. Seay MD, Calix RA, Digre KB (2023). A Great Conversation With Kathleen Digre. J Neuroophthalmol. ()
    17. Seay MD, Calix RA, Digre KB (2022). A Great Conversation With Larry Frohman. J Neuroophthalmol. ()
    18. Brady T, Vegunta S, Crum AV, Marx D, Patel BCK, Seay MD, Schmidt RH, Warner JEA, Digre KB, Katz BJ (2022). Interdisciplinary Protocol for the Management of Vision-Threatening Papilledema. J Neuroophthalmol, 42(4), 495-501. ()
    19. Digre KB, Seay MD (2022). The American Headache Society Met in Denver, June 9, 2022. J Neuroophthalmol, 42(4), e606. ()
    20. Digre KB, Seay MD (2022). 15th European Neuro-Ophthalmology Society Meeting, Birmingham, England, June 20-23, 2022. J Neuroophthalmol, 42(4), e604-e605. ()
    21. Seay MD, Calix RA, Digre KB (2022). A Great Conversation With John (Jack) B. Selhorst. J Neuroophthalmol, 42(4), e558-e561. ()
    22. Seay MD (2022). The 59th Annual International Society for Clinical Electrophysiology of Vision Meeting in Liverpool, United Kingdom. J Neuroophthalmol. ()
    23. Seay MD, Digre KB (2022). Idiopathic Intracranial Hypertension from Benign to Fulminant: Diagnostic and Management Issues. Ann Indian Acad Neurol, 25(Suppl 2), S59-S64. ()
    24. Macaron G, Khoury J, Bena J, Seay M, Bermel RA, Cohen JA, Rensel MR (2021). Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorder. Mult Scler, 1352458520981736. ()
    25. Seay MD, Digre KB, Galetta SL (2020). Dr. Norman Schatz. J Neuroophthalmol, 40(4), e65-e73. ()
    26. Sun MM, Seleme N, Chen JJ, Zekeridou A, Sechi E, Walsh RD, Beebe JD, Sabbagh O, Mejico LJ, Gratton S, Skidd PM, Bellows DA, Falardeau J, Fraser CL, Cappelen-Smith C, Haines SR, Hassanzadeh B, Seay MD, Subramanian PS, Williams Z, Gordon LK (2020). Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade. J Neuroophthalmol. ()
    27. Seay MD, Digre KB (2020). Klara Landau's Retirement From ÈËÆÞÖгöÊÓƵ Chair and European Neuro-Ophthalmology Society 2018 Course Both Occur in Switzerland. J Neuroophthalmol, 40(2), e7-e8. ()
    28. Seay MD, Digre KB (2020). European Neuro-Ophthalmology Society Meeting, June 16-19, 2019, Porto, Portugal. J Neuroophthalmol, 40(2), e9-e10. ()
    29. Seay M, Fortin E, Digre K (2019). Great Conversations: Dr. Barrett Katz. J Neuroophthalmol, 39(3), e13-e14. ()
    30. Seay MD, Lau H, Galetta SL (2019). Teaching NeuroImages: Scleral thickening and optic disc edema from glycosaminoglycan deposition in Hunter syndrome. Neurology, 92(13), e1532-e1533. ()
    31. Seay M, Galetta S (2018). Glial Fibrillary Acidic Protein Antibody: Another Antibody in the Multiple Sclerosis Diagnostic Mix. J Neuroophthalmol, 38(3), 281-284. ()
    32. Abboud H, Mente K, Seay M, Kim J, Ali A, Bermel R, Willis MA (2017). Triaging Patients with Multiple Sclerosis in the Emergency Department: Room for Improvement. Int J MS Care, 19(6), 290-6. ()

    Newspaper

    1. Seay MD, Digre KB (2023). The 49th Annual Meeting of the North American Neuro-Ophthalmology Society in Orlando, Florida. J Neuroophthalmol, pp. e89-e90. ()
    2. Lombardo NT, Seay MD, Hull BE, Digre KB, Kedar S (2023). NANOS Illustrated Curriculum for Neuro-Ophthalmology. J Neuroophthalmol, pp. e21-e24. ()

    Other

    1. Seay M, Digre K (2020). The 46th Annual Meeting of the North American Neuro-Ophthalmology Society in Amelia Island, Florida. J Neuroophthalmol (40(3), pp. e27-e28). United States. ()
    2. Seay MD (2020). American Academy of Ophthalmology and Neuro-Ophthalmology Subspecialty Day 2019 Summary. J Neuroophthalmol (40(1), pp. e1-e2). United States. ()
    3. Seay M, Digre K (2019). The 45th Annual Meeting of the North American Neuro-Ophthalmology Society in Las Vegas, Nevada. J Neuroophthalmol (39(3), pp. e10-e12). United States. ()